For Alzheimer’s disease, striking genetic analyses have shown that human mutations in APP that promote the production of A-ß also promote Alzheimer’s disease and mutations that specifically reduce A-ß production confer resistance (Jonsson et al. 2012). This evidence concerns the gene APP and Alzheimer disease.